Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: Evaluation of a heparin-coated bypass circuit

N. A. Francalancia, R. Aeba, S. A. Yousem, B. P. Griffith, G. C. Marrone

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Clinical lung transplantation may necessitate the use of cardiopulmonary bypass during the procedure, resulting in increased morbidity with more severe early graft dysfunction and increased blood loss. A heparin surface- coated cardiopulmonary bypass circuit is now available with improved biocompatibility and reduced systemic heparin requirements and may offer advantages compared with standard uncoated cardiopulmonary bypass circuits. This study investigates in a canine model of single-lung allotransplantation whether cardiopulmonary bypass adversely affects early graft function and whether a heparin-coated cardiopulmonary bypass circuit with reduced systemic heparin dosage improves results compared with standard uncoated cardiopulmonary bypass systems. Fifteen dogs underwent left single-lung allotransplantation with occlusion of the contralateral pulmonary artery and bronchus 1 hour after reperfusion. In one group, five animals underwent the procedure without cardiopulmonary bypass. In the group with uncoated circuits, five animals underwent the procedure with the use of standard uncoated cardiopulmonary bypass circuits with full systemic heparin dosage. In the group with heparin-coated circuits, five animals underwent the procedure with the use of heparin-coated cardiopulmonary bypass circuits and reduced systemic heparin dosage. Early graft function was evaluated by arterial oxygenation, pulmonary mechanics, lung water measurements, and histologic analysis. Hemodynamics and postoperative blood loss were also measured. Two hours after reperfusion, partial pressure of oxygen in arterial blood on an inspired oxygen fraction = 1.0 was significantly greater (p < 0.001) in the group without cardiopulmonary bypass (467 ± 58 mm Hg) than in the group with uncoated circuits (114 ± 90 mm Hg) and the group with heparin-coated circuits (193 ± 105 mm Hg), with no significant difference between the groups undergoing bypass procedures. Lung compliance decreased and lung water increased in all transplanted lungs without significant differences between groups. Histologic analysis did not differentiate between the groups. After reperfusion, cardiac index and mean arterial pressure were significantly reduced in the groups with uncoated circuits and with heparin- coated circuits compared with the group that did not undergo cardiopulmonary bypass (p < 0.001). Postoperative blood loss was significantly less (p < 0.002) in the group that did not undergo cardiopulmonary bypass (90 ml ± 38 ml) compared with both the group with uncoated circuits (750 ± 15 ml) and the group with heparin-coated circuits (690 ± 387 ml), with no significant difference between the groups that underwent bypass. The use of cardiopulmonary bypass with systemic heparinization is detrimental to early graft function in this canine model of left single-lung allotransplantation. Heparin-coated cardiopulmonary bypass circuits with reduced systemic heparin dosage did not provide benefits compared with standard uncoated cardiopulmonary bypass circuits with full systemic heparinization.

Original languageEnglish
Pages (from-to)498-507
Number of pages10
JournalJournal of Heart and Lung Transplantation
Volume13
Issue number3
Publication statusPublished - 1994
Externally publishedYes

Fingerprint

Cardiopulmonary Bypass
Heparin
Transplants
Lung
Reperfusion
Postoperative Hemorrhage
Canidae
Oxygen
Lung Compliance
Lung Transplantation
Water
Partial Pressure
Bronchi
Mechanics
Pulmonary Artery
Arterial Pressure
Hemodynamics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Transplantation

Cite this

Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation : Evaluation of a heparin-coated bypass circuit. / Francalancia, N. A.; Aeba, R.; Yousem, S. A.; Griffith, B. P.; Marrone, G. C.

In: Journal of Heart and Lung Transplantation, Vol. 13, No. 3, 1994, p. 498-507.

Research output: Contribution to journalArticle

@article{216aff9145dd47259d709db509af8dd6,
title = "Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: Evaluation of a heparin-coated bypass circuit",
abstract = "Clinical lung transplantation may necessitate the use of cardiopulmonary bypass during the procedure, resulting in increased morbidity with more severe early graft dysfunction and increased blood loss. A heparin surface- coated cardiopulmonary bypass circuit is now available with improved biocompatibility and reduced systemic heparin requirements and may offer advantages compared with standard uncoated cardiopulmonary bypass circuits. This study investigates in a canine model of single-lung allotransplantation whether cardiopulmonary bypass adversely affects early graft function and whether a heparin-coated cardiopulmonary bypass circuit with reduced systemic heparin dosage improves results compared with standard uncoated cardiopulmonary bypass systems. Fifteen dogs underwent left single-lung allotransplantation with occlusion of the contralateral pulmonary artery and bronchus 1 hour after reperfusion. In one group, five animals underwent the procedure without cardiopulmonary bypass. In the group with uncoated circuits, five animals underwent the procedure with the use of standard uncoated cardiopulmonary bypass circuits with full systemic heparin dosage. In the group with heparin-coated circuits, five animals underwent the procedure with the use of heparin-coated cardiopulmonary bypass circuits and reduced systemic heparin dosage. Early graft function was evaluated by arterial oxygenation, pulmonary mechanics, lung water measurements, and histologic analysis. Hemodynamics and postoperative blood loss were also measured. Two hours after reperfusion, partial pressure of oxygen in arterial blood on an inspired oxygen fraction = 1.0 was significantly greater (p < 0.001) in the group without cardiopulmonary bypass (467 ± 58 mm Hg) than in the group with uncoated circuits (114 ± 90 mm Hg) and the group with heparin-coated circuits (193 ± 105 mm Hg), with no significant difference between the groups undergoing bypass procedures. Lung compliance decreased and lung water increased in all transplanted lungs without significant differences between groups. Histologic analysis did not differentiate between the groups. After reperfusion, cardiac index and mean arterial pressure were significantly reduced in the groups with uncoated circuits and with heparin- coated circuits compared with the group that did not undergo cardiopulmonary bypass (p < 0.001). Postoperative blood loss was significantly less (p < 0.002) in the group that did not undergo cardiopulmonary bypass (90 ml ± 38 ml) compared with both the group with uncoated circuits (750 ± 15 ml) and the group with heparin-coated circuits (690 ± 387 ml), with no significant difference between the groups that underwent bypass. The use of cardiopulmonary bypass with systemic heparinization is detrimental to early graft function in this canine model of left single-lung allotransplantation. Heparin-coated cardiopulmonary bypass circuits with reduced systemic heparin dosage did not provide benefits compared with standard uncoated cardiopulmonary bypass circuits with full systemic heparinization.",
author = "Francalancia, {N. A.} and R. Aeba and Yousem, {S. A.} and Griffith, {B. P.} and Marrone, {G. C.}",
year = "1994",
language = "English",
volume = "13",
pages = "498--507",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation

T2 - Evaluation of a heparin-coated bypass circuit

AU - Francalancia, N. A.

AU - Aeba, R.

AU - Yousem, S. A.

AU - Griffith, B. P.

AU - Marrone, G. C.

PY - 1994

Y1 - 1994

N2 - Clinical lung transplantation may necessitate the use of cardiopulmonary bypass during the procedure, resulting in increased morbidity with more severe early graft dysfunction and increased blood loss. A heparin surface- coated cardiopulmonary bypass circuit is now available with improved biocompatibility and reduced systemic heparin requirements and may offer advantages compared with standard uncoated cardiopulmonary bypass circuits. This study investigates in a canine model of single-lung allotransplantation whether cardiopulmonary bypass adversely affects early graft function and whether a heparin-coated cardiopulmonary bypass circuit with reduced systemic heparin dosage improves results compared with standard uncoated cardiopulmonary bypass systems. Fifteen dogs underwent left single-lung allotransplantation with occlusion of the contralateral pulmonary artery and bronchus 1 hour after reperfusion. In one group, five animals underwent the procedure without cardiopulmonary bypass. In the group with uncoated circuits, five animals underwent the procedure with the use of standard uncoated cardiopulmonary bypass circuits with full systemic heparin dosage. In the group with heparin-coated circuits, five animals underwent the procedure with the use of heparin-coated cardiopulmonary bypass circuits and reduced systemic heparin dosage. Early graft function was evaluated by arterial oxygenation, pulmonary mechanics, lung water measurements, and histologic analysis. Hemodynamics and postoperative blood loss were also measured. Two hours after reperfusion, partial pressure of oxygen in arterial blood on an inspired oxygen fraction = 1.0 was significantly greater (p < 0.001) in the group without cardiopulmonary bypass (467 ± 58 mm Hg) than in the group with uncoated circuits (114 ± 90 mm Hg) and the group with heparin-coated circuits (193 ± 105 mm Hg), with no significant difference between the groups undergoing bypass procedures. Lung compliance decreased and lung water increased in all transplanted lungs without significant differences between groups. Histologic analysis did not differentiate between the groups. After reperfusion, cardiac index and mean arterial pressure were significantly reduced in the groups with uncoated circuits and with heparin- coated circuits compared with the group that did not undergo cardiopulmonary bypass (p < 0.001). Postoperative blood loss was significantly less (p < 0.002) in the group that did not undergo cardiopulmonary bypass (90 ml ± 38 ml) compared with both the group with uncoated circuits (750 ± 15 ml) and the group with heparin-coated circuits (690 ± 387 ml), with no significant difference between the groups that underwent bypass. The use of cardiopulmonary bypass with systemic heparinization is detrimental to early graft function in this canine model of left single-lung allotransplantation. Heparin-coated cardiopulmonary bypass circuits with reduced systemic heparin dosage did not provide benefits compared with standard uncoated cardiopulmonary bypass circuits with full systemic heparinization.

AB - Clinical lung transplantation may necessitate the use of cardiopulmonary bypass during the procedure, resulting in increased morbidity with more severe early graft dysfunction and increased blood loss. A heparin surface- coated cardiopulmonary bypass circuit is now available with improved biocompatibility and reduced systemic heparin requirements and may offer advantages compared with standard uncoated cardiopulmonary bypass circuits. This study investigates in a canine model of single-lung allotransplantation whether cardiopulmonary bypass adversely affects early graft function and whether a heparin-coated cardiopulmonary bypass circuit with reduced systemic heparin dosage improves results compared with standard uncoated cardiopulmonary bypass systems. Fifteen dogs underwent left single-lung allotransplantation with occlusion of the contralateral pulmonary artery and bronchus 1 hour after reperfusion. In one group, five animals underwent the procedure without cardiopulmonary bypass. In the group with uncoated circuits, five animals underwent the procedure with the use of standard uncoated cardiopulmonary bypass circuits with full systemic heparin dosage. In the group with heparin-coated circuits, five animals underwent the procedure with the use of heparin-coated cardiopulmonary bypass circuits and reduced systemic heparin dosage. Early graft function was evaluated by arterial oxygenation, pulmonary mechanics, lung water measurements, and histologic analysis. Hemodynamics and postoperative blood loss were also measured. Two hours after reperfusion, partial pressure of oxygen in arterial blood on an inspired oxygen fraction = 1.0 was significantly greater (p < 0.001) in the group without cardiopulmonary bypass (467 ± 58 mm Hg) than in the group with uncoated circuits (114 ± 90 mm Hg) and the group with heparin-coated circuits (193 ± 105 mm Hg), with no significant difference between the groups undergoing bypass procedures. Lung compliance decreased and lung water increased in all transplanted lungs without significant differences between groups. Histologic analysis did not differentiate between the groups. After reperfusion, cardiac index and mean arterial pressure were significantly reduced in the groups with uncoated circuits and with heparin- coated circuits compared with the group that did not undergo cardiopulmonary bypass (p < 0.001). Postoperative blood loss was significantly less (p < 0.002) in the group that did not undergo cardiopulmonary bypass (90 ml ± 38 ml) compared with both the group with uncoated circuits (750 ± 15 ml) and the group with heparin-coated circuits (690 ± 387 ml), with no significant difference between the groups that underwent bypass. The use of cardiopulmonary bypass with systemic heparinization is detrimental to early graft function in this canine model of left single-lung allotransplantation. Heparin-coated cardiopulmonary bypass circuits with reduced systemic heparin dosage did not provide benefits compared with standard uncoated cardiopulmonary bypass circuits with full systemic heparinization.

UR - http://www.scopus.com/inward/record.url?scp=0028276879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028276879&partnerID=8YFLogxK

M3 - Article

C2 - 8061027

AN - SCOPUS:0028276879

VL - 13

SP - 498

EP - 507

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 3

ER -